Template-Guided Burr-Hole Drainage With Middle Meningeal Artery Coagulation for Chronic Subdural Hematoma

Официальное название

Three-Dimensional Printed Template-Guided Burr-Hole Drainage Combined With Intraoperative Middle Meningeal Artery Coagulation for Preventing Recurrence of Chronic Subdural Hematoma: A Multicenter Randomized Controlled Trial

Обзор

Chronic subdural hematoma is a collection of blood and fluid on the surface of the brain that is common in older adults. Burr-hole drainage is a standard surgical treatment, but the hematoma may come back in some patients and require another procedure.This study will test whether using a patient-specific 3D-printed template to guide burr-hole placement, combined with coagulation of the middle meningeal artery during surgery, can reduce the risk of hematoma recurrence compared with standard burr-hole drainage.Participants with symptomatic chronic subdural hematoma who need surgery will be randomly assigned to one of two groups. One group will receive standard burr-hole drainage. The other group will receive 3D-printed template-guided burr-hole drainage with attempted intraoperative frontal branch of the middle meningeal artery coagulation when it can be safely performed.The main outcome is whether the hematoma comes back and requires another invasive treatment within 3 months after surgery. The study will also assess brain imaging results, neurological recovery, complications, hospital stay, and the feasibility and safety of the 3D-printed template and artery coagulation procedure.

Подробное описание

Chronic subdural hematoma is a common neurosurgical disease, especially in older adults. Burr-hole drainage with closed-system drainage is widely used as standard surgical treatment. However, recurrence after surgery remains an important clinical problem and may require repeat invasive treatment.

The middle meningeal artery is believed to contribute to the blood supply of the outer membrane of chronic subdural hematoma. Interruption of middle meningeal artery flow may reduce repeated microbleeding and fluid exudation from the hematoma membrane. Endovascular middle meningeal artery embolization has shown promising results, but it requires angiographic equipment, interventional expertise, embolic materials, and additional cost.

This study evaluates a surgical strategy that combines patient-specific 3D-printed template guidance with burr-hole drainage and intraoperative middle meningeal artery coagulation. Preoperative thin-slice computed tomography images will be used to plan the burr-hole location and design a 3D-printed template. The template is intended to help surgeons locate a burr-hole site related to the expected course of the middle meningeal artery(frontal branch) while still allowing effective hematoma drainage.

Participants with symptomatic chronic subdural hematoma requiring burr-hole drainage will be randomly assigned to receive either standard burr-hole drainage or 3D-printed template-guided burr-hole drainage with attempted intraoperative middle meningeal artery coagulation when safely feasible.

The study will test whether this approach can reduce recurrence requiring repeat invasive treatment within 3 months after surgery. It will also assess clinical recovery, radiological changes, complications, resource use, and the feasibility and safety of template-guided localization and intraoperative artery coagulation.Patient safety will take priority over completion of the coagulation step. If the middle meningeal artery or a related branch cannot be clearly identified or safely coagulated during surgery, coagulation will not be performed, and standard hematoma drainage will be completed.

Вмешательства

• Процедура Standard Burr-Hole Drainage Group
  Standard burr-hole drainage performed according to routine clinical practice for chronic subdural hematoma.
• Процедура 3D-Printed Template-Guided Burr-Hole Drainage With Attempted MMA Coagulation Group
  Burr-hole drainage performed using a patient-specific 3D-printed template for surgical guidance, combined with attempted intraoperative coagulation of the middle meningeal artery.

Первичные конечные точки

• Recurrence of Chronic Subdural Hematoma Requiring Invasive Re-intervention within 3 Months after Surgery [Срок оценки: Within 3 months after surgery]

Вторичные конечные точки (6)

• Incidence of cSDH Recurrence (Hematoma Progression) [Срок оценки: Within 3 months after surgery]
• Functional Outcome Measured by the Modified Rankin Scale (mRS) [Срок оценки: Within 3 months after surgery]
• MMA identification rate [Срок оценки: Intra-operative]
• Number of participants experiencing one or more peri-operative surgical or medical complications [Срок оценки: Intra-operative through 30 days post-operatively]
• Length of Hospital Stay [Срок оценки: up to 30 days]
• All-cause Mortality [Срок оценки: Within 3 months after surgery]

Критерии участия

Критерии включения

• Patients diagnosed with chronic subdural hematoma based on clinical symptoms and cranial CT or MRI.
• Patients scheduled to undergo burr-hole drainage surgery.
• Age 18 years or older.
• Written informed consent obtained from the patient or legal representative. Exclusion Criteria
• Acute subdural hematoma or other intracranial lesions requiring different surgical management.
• Previous surgery for the same episode of chronic subdural hematoma.
• Severe coagulation disorder or other contraindications to surgery.
• Severe systemic disease making the patient unsuitable for participation.
• Refusal or inability to provide informed consent.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Простое слепое

Основная цель

Лечение

Центры проведения

Китай · 1 центр

• The Second Affiliated Hospital of Anhui Medical University — Хэфэй

Идентификаторы

NCT: NCT07720687 · SAHAMU-CSDH-RCT-001 · 202512022

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗